Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN66284870
ISRCTN66284870
Completed
Not Applicable

Randomised controlled trial of Skin Prick Testing

Brighton and Sussex University Hospitals NHS Trust (UK)0 sites528 target enrollmentJune 6, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Brighton and Sussex University Hospitals NHS Trust (UK)
Enrollment
528
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 6, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Brighton and Sussex University Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •Patients with a working diagnosis of asthma and/or rhinoconjunctivitis

Exclusion Criteria

  • •1\. Less than 5 years or greater than 50 years
  • •2\. Terminal illness
  • •3\. Confusional state
  • •4\. History of anaphylaxis
  • •5\. Tested in the preceding two years

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Clinical trial to estimate role of topical vitamin A on chronic wounds.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
CTRI/2024/03/064005DRMonishaS
Not yet recruiting
Not Applicable
Evaluation of four types of therapies for the treatment of urogenital atrophy in postmenopausal womeIn postmenopausal women with symptoms of urogenital atrophyN95.2
RBR-2wjrp4Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM Unicamp
Completed
Phase 2
Randomized controlled trial of taping patients with a shoulder subacromial impingement syndromeshoulder complaintssubacromial impingement syndrome10043237
NL-OMON35014Academisch Medisch Centrum140
Active, not recruiting
Phase 1
Subcutaneous verus intravenous morphine in palliative cancer patientsCancer pain not responding to oral opioids in palliative cancer patient, where switching to the parenteral route is indicated.Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]
EUCTR2021-003427-14-NOAkershus University Hospital60
Active, not recruiting
Not Applicable
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Total Hip Replacement. - (TRANX-H)Blood loss in total hip replacement in patient with ostoearthritis and rheumatoid arthritis.
EUCTR2009-012141-34-GBniversity Hospital of North Tees and Hartlepool150